For more than 25 years, Bionics Institute researchers have been supported by a wonderful partnership with the Bertalli Family Foundation.
In November, Neville and Di Bertalli met with Bionics Institute researchers Professor James Fallon, A/Prof Sophie Payne and Dr Tomoko Hyakumura to mark a milestone in this partnership, which has significantly contributed to the development of the Bionics Institute’s abdominal vagus nerve stimulation device that is now in clinical trials for Crohn’s disease and rheumatoid arthritis, and now under investigation as a treatment for epilepsy and Parkinson’s disease.
“When we first met James over a decade ago the Institute was embarking on this groundbreaking research. We are delighted to support James, Sophie, Tomoko and the Bionics Institute team to progress their research through to clinical trials, and look forward to seeing many more to come,” he said.
Bionics Institute CEO Robert Klupacs said: “Neville and Di have seen the world benefit from the many leaps forward in medical research, like the cochlear implant. Their passion for ensuring the continued progression of innovative new treatments led to Neville spending many years sharing his extensive business knowledge as a member of the Bionics Institute Board, and their dedication has been instrumental in nurturing the next generation of brilliant minds to transform lives.”
Professor Fallon says: “Neville and Di’s inspiring commitment to helping others through their support of medical research has had a major impact on the Bionics Institute that will last for years to come, and we are very grateful for their support.”
Find out about plans to investigate many more diseases through the Bionics Institute Vagus Nerve Stimulation Centre of Excellence, featured in the video below.
Vagus Nerve Stimulation Centre of Excellence at the Bionics Institute
“Neville and Di’s inspiring commitment to helping others through their support of medical research has had a major impact on the Bionics Institute that will last for years to come, and we are very grateful for their support.” Professor James Fallon
